Intellia Therapeutics, Inc. (NTLA)
11.64
-0.36
(-3.04%)
USD |
NASDAQ |
Feb 12, 16:00
11.65
+0.02
(+0.13%)
After-Hours: 19:36
Intellia Therapeutics Market Cap : 1.348B for Feb. 12, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Beam Therapeutics, Inc. | 2.732B |
| Regeneron Pharmaceuticals, Inc. | 82.86B |
| Pacific Biosciences of California, Inc. | 557.02M |
| Personalis, Inc. | 742.40M |
| Twist Bioscience Corp. | 2.923B |
Market Cap Related Metrics
| PS Ratio | 21.20 |
| Price to Book Value | 1.801 |
| Price | 11.64 |
| Earnings Yield | -36.66% |